Intrommune Toothpaste Immunotherapy for Peanut Allergy Shows High Patient Compliance for Phase 1 Intrommune Theraputics is pleased with high patient compliance, over 90%, in Phase 1 of the Toothpaste Immunotherapy study. Intrommune‚Äôs Toothpaste Immunotherapy for Peanut Allergy Completes Phase 1 Enrollment ByDave Bloom -2022/10/28 391 Share Observed only mild and transient adverse events, with no use of [...]